Cargando…

Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial

AIMS: The association of body weight and weight change with mortality and cardiovascular (CV) outcome in patients with diabetes mellitus (DM) is not clearly established. We assessed the relationship between weight, weight change, and outcomes in patients with established CV risk factors and type 2 D...

Descripción completa

Detalles Bibliográficos
Autores principales: Doehner, Wolfram, Gerstein, Hertzel C, Ried, Janina, Jung, Hyejung, Asbrand, Christian, Hess, Sibylle, Anker, Stefan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377581/
https://www.ncbi.nlm.nih.gov/pubmed/32402060
http://dx.doi.org/10.1093/eurheartj/ehaa293
_version_ 1783562244072669184
author Doehner, Wolfram
Gerstein, Hertzel C
Ried, Janina
Jung, Hyejung
Asbrand, Christian
Hess, Sibylle
Anker, Stefan D
author_facet Doehner, Wolfram
Gerstein, Hertzel C
Ried, Janina
Jung, Hyejung
Asbrand, Christian
Hess, Sibylle
Anker, Stefan D
author_sort Doehner, Wolfram
collection PubMed
description AIMS: The association of body weight and weight change with mortality and cardiovascular (CV) outcome in patients with diabetes mellitus (DM) is not clearly established. We assessed the relationship between weight, weight change, and outcomes in patients with established CV risk factors and type 2 DM or pre-diabetes. METHODS AND RESULTS: A total of 12 521 participants from the ORIGIN trial were grouped in BMI categories of low body weight [body mass index (BMI) < 22 kg/m(2)] normal (22–24.9), overweight (25–29.9), obesity Grades 1–3 (30–34.9, 35–39.9, ≥40 kg/m(2), respectively). Outcome variables included total and CV mortality and composite outcomes of CV death, non-fatal stroke, or myocardial infarction plus revascularization or heart failure hospitalization. Follow-up was 6.2 years (interquartile range 5.8–6.7 years). After multivariable adjustment, lowest risks were seen in patients with overweight and mild obesity for total mortality [overweight: hazard ratio (HR) 0.80 (95% confidence interval (CI) 0.69–0.91); obesity Grade 1: HR 0.82 (0.71–0.95), both P < 0.01)] and CV mortality [overweight: HR 0.79 (0.66–0.94); obesity Grade 1: 0.79 (0.65–0.95), all compared to patients with normal BMI, P < 0.05]. Obesity of any severity was not associated with higher mortality. Low body weight was related to higher mortality [HR 1.28 (1.02–1.61); CV mortality: HR 1.34 (1.01–1.79), P < 0.05]. A continued 2-year weight loss was associated with higher risk of mortality [HR 1.32 (1.18–1.46), P < 0.0001] and CV mortality [HR 1.18 (1.02–1.35), compared to patients without weight loss, P < 0.05]. In turn, weight gain was not related to any adverse outcome. CONCLUSION: Obesity in patients with DM or pre-diabetes and CV risk profile was not associated with higher mortality or adverse CV outcome. The lowest mortality risk was seen in patients with overweight and moderate obesity (BMI 25–35 kg/m(2)). Weight loss was an independent risk factor for higher mortality compared to no weight loss.
format Online
Article
Text
id pubmed-7377581
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-73775812020-07-28 Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial Doehner, Wolfram Gerstein, Hertzel C Ried, Janina Jung, Hyejung Asbrand, Christian Hess, Sibylle Anker, Stefan D Eur Heart J Clinical Research AIMS: The association of body weight and weight change with mortality and cardiovascular (CV) outcome in patients with diabetes mellitus (DM) is not clearly established. We assessed the relationship between weight, weight change, and outcomes in patients with established CV risk factors and type 2 DM or pre-diabetes. METHODS AND RESULTS: A total of 12 521 participants from the ORIGIN trial were grouped in BMI categories of low body weight [body mass index (BMI) < 22 kg/m(2)] normal (22–24.9), overweight (25–29.9), obesity Grades 1–3 (30–34.9, 35–39.9, ≥40 kg/m(2), respectively). Outcome variables included total and CV mortality and composite outcomes of CV death, non-fatal stroke, or myocardial infarction plus revascularization or heart failure hospitalization. Follow-up was 6.2 years (interquartile range 5.8–6.7 years). After multivariable adjustment, lowest risks were seen in patients with overweight and mild obesity for total mortality [overweight: hazard ratio (HR) 0.80 (95% confidence interval (CI) 0.69–0.91); obesity Grade 1: HR 0.82 (0.71–0.95), both P < 0.01)] and CV mortality [overweight: HR 0.79 (0.66–0.94); obesity Grade 1: 0.79 (0.65–0.95), all compared to patients with normal BMI, P < 0.05]. Obesity of any severity was not associated with higher mortality. Low body weight was related to higher mortality [HR 1.28 (1.02–1.61); CV mortality: HR 1.34 (1.01–1.79), P < 0.05]. A continued 2-year weight loss was associated with higher risk of mortality [HR 1.32 (1.18–1.46), P < 0.0001] and CV mortality [HR 1.18 (1.02–1.35), compared to patients without weight loss, P < 0.05]. In turn, weight gain was not related to any adverse outcome. CONCLUSION: Obesity in patients with DM or pre-diabetes and CV risk profile was not associated with higher mortality or adverse CV outcome. The lowest mortality risk was seen in patients with overweight and moderate obesity (BMI 25–35 kg/m(2)). Weight loss was an independent risk factor for higher mortality compared to no weight loss. Oxford University Press 2020-05-13 /pmc/articles/PMC7377581/ /pubmed/32402060 http://dx.doi.org/10.1093/eurheartj/ehaa293 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research
Doehner, Wolfram
Gerstein, Hertzel C
Ried, Janina
Jung, Hyejung
Asbrand, Christian
Hess, Sibylle
Anker, Stefan D
Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title_full Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title_fullStr Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title_full_unstemmed Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title_short Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
title_sort obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the origin trial
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377581/
https://www.ncbi.nlm.nih.gov/pubmed/32402060
http://dx.doi.org/10.1093/eurheartj/ehaa293
work_keys_str_mv AT doehnerwolfram obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT gersteinhertzelc obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT riedjanina obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT junghyejung obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT asbrandchristian obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT hesssibylle obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial
AT ankerstefand obesityandweightlossareinverselyrelatedtomortalityandcardiovascularoutcomeinprediabetesandtype2diabetesdatafromtheorigintrial